BOLT

4.9102.96%
RS

Ryan Sullivan

Chief Scientific Officer

Dr. Ryan Sullivan is Chief Scientific Officer of Prana Therapies, Inc. ( acquired company of Bolt Biotherapeutics, Inc.). Dr. Sullivan was VP CSO Partner Team of Curie Bio Operations, LLC from May 2023 till 2026. Dr. Sullivan was Vice President & Head of NK Research of Wugen Inc. until 2023. Dr. Sullivan was employed at Wugen Inc. until 2023. Dr. Sullivan has Ph.D. in Immunology from Washington University, St. Louis.

Positions